There is no content at this time. Please check back later.
Your questions answered - Fall 2017
Read the full articleThe College has gone through a lot of changes under Vision 2020 to better serve practicing allergists, and we recognize… The College has gone through a lot of changes under Vision 2020 to better serve practicing allergists, and we recognize the importance of involving our…

Practice resources tailored to your needs
Read the full articleAs health care continues to evolve, it can be challenging to keep up with all the changes. That’s why the… As health care continues to evolve, it can be challenging to keep up with all the changes. That’s why the College has taken great strides…

Medicare is Removing Social Security Numbers From Medicare Cards
Read the full articleTo protect seniors from identify theft and to save taxpayer dollars, the Centers for Medicare & Medicaid Services (CMS) will… To protect seniors from identify theft and to save taxpayer dollars, the Centers for Medicare & Medicaid Services (CMS) will be replacing the Social Security…

High-five – Hone your clinical trial skills
Read the full articleEvery month we want to give a shout out – a high five – to a great member resource on… Every month we want to give a shout out – a high five – to a great member resource on the College website. This month,…

Membership Types
Read the full articleACAAI Membership Types Joining your colleagues in the American College of Allergy, Asthma & Immunology unlocks opportunities and benefits found… ACAAI Membership Types Joining your colleagues in the American College of Allergy, Asthma & Immunology unlocks opportunities and benefits found nowhere else. Member For physicians…

National Asthma and Allergy Awareness Month Article Templates
in Marketing & Patient Materials | Resource Type: ZIPRead the full articleDuring Asthma and Allergy Awareness Month in May, use these materials to distribute information to your local media, upload content to your website and/or newsletter, or use in an informational flyer for patients. …

CPT code 95165 - What’s a dose for Medicare billing?
Read the full articleMedicare defines a dose, for billing purposes only, as 1cc of extract and does not cover dilutions. Medicare reimbursement is… Allergists commonly bill CPT code 95165, which describes services for the supervision of preparation and provision of antigens for allergen immunotherapy. It is important…

Nominate a FIT for 2024 Annals Award
Read the full articleFITs who publish the best original research or review in Annals will receive a cash award of up to $2,500. Multiple… Have you read outstanding original research or an excellent review in Annals of Allergy, Asthma & Immunology written by a Fellow-in-Training? Consider nominating them…

Get ready for Asthma and Allergy Awareness month 2024
Read the full articleBe prepared for this awareness month, when attention is focused on asthma and allergies. It’s a great opportunity to share… Coming soon – National Asthma and Allergy Awareness Month in May! You’ll want to be prepared for this awareness month, when attention is focused…

2023 MIPS Emergency Exception Applications reopened due to Change Healthcare cyberattack
Read the full articleCMS will only approve applications citing this cyberattack as the basis for requesting reweighting under the MIPS EUC Exception.… In response to the Change Healthcare cyberattack in late February, CMS extended the 2023 MIPS data submission deadline and is now reopening the 2023 MIPS…

Coding Conundrum – E/M plus Testing
Read the full articleRecently we received a query from a member about coding an oral challenge and an office visit on the same… The Advocacy Council often receives queries from members on correctly coding specific scenarios. Recently we received a request about coding an oral challenge and…

Change Healthcare Cyberattack - continuing coverage
Read the full articleHere is the latest update from UnitedHealth Group. We encourage you to bookmark and check the UHG site regularly for… The Advocacy Council is aware many practices have experienced devastating fallout from the Change Healthcare cyberattack – an issue directly affecting cash flow that…

March 2024 Annals highlights
Read the full articleThis month’s articles and reviews provide guidance for these changes in our treatment pathways.… As spring arrives and pollen season begins, the current issue of Annals of Allergy, Asthma and Immunology highlights many of the new changes that are coming to our field. As…

It takes a village
Read the full articleWhat does it take to bring the ACAAI Annual Scientific Meeting to life each year? Believe it or not, planning… One of the most interesting parts of being president of the College is the ability to see many things “up close and personal” that…

AllergyTalk: Two Special Podcasts: Omalizumab for Food Allergy
Read the full articleOn February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy,… On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy, omalizumab.…

2024 Cyberattacks cause disruptions
Read the full articleDue to the attack, Change Healthcare's systems are still down, causing struggles for physician practices and hospitals filing claims, as… On Feb. 21, Optum announced that its subsidiary, Change Healthcare, was the victim of a massive cyberattack. Change Healthcare is one of the largest…

Omalizumab for Food Allergy Part 2: Implementation Into Practice
in AllergyTalkRead the full articleIn Part 2, we will discuss important considerations in implementing omalizumab for food allergy in your practice.… On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy, omalizumab! In first part of a two-part…

Omalizumab For Food Allergy – Part 1: Reviewing the Evidence
in AllergyTalkRead the full articleIn first part of a two-part series, we will review the evidence behind the Omalizumab as Monotherapy and as Adjunct… On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy, omalizumab! In first part…

AllergyTalk podcast features OUtMATCH study
Read the full articleThe FDA announced its approval of omalizumab as the first biologic medication to treat patients with food allergy.… As the College previously reported, on Feb. 16, the FDA announced its approval of omalizumab as the first biologic medication to treat patients with food allergy.…

ERROR!